These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 7268885)

  • 1. Enhancement and antibody-mediated rejection of mouse skin allografts with anti-H-2K, H-2D, H-2L antibodies.
    Capel PJ; de Waal RM; Démant P; Koene RA
    Transplant Proc; 1981 Mar; 13(1 Pt 1):649-53. PubMed ID: 7268885
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of anti-H-2K and H-2D alloantibodies in enhancement and acute antibody-mediated rejection of mouse skin allografts.
    de Waal RM; Capel PJ; Koene RA
    J Immunol; 1980 Feb; 124(2):719-23. PubMed ID: 6985936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune regulation by monoclonal antibodies: failure to enhance mouse skin allografts.
    Lems SP; Tax WJ; Capel PJ; Koene RA
    J Immunol; 1983 Jul; 131(1):86-91. PubMed ID: 6345667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone grafting in inbred mice: evidence for H-2K, H-2D, and non-H-2 antigens in bone.
    Halloran PF; Lee E; Ziv I; Langer F
    Transplant Proc; 1979 Jun; 11(2):1507-9. PubMed ID: 382551
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of histocompatibility in graft rejection.
    McKenzie IF
    Transplant Proc; 1979 Mar; 11(1):628-32. PubMed ID: 313098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage MHC receptor 2: a novel receptor on allograft (H-2D(d)K(d))-induced macrophage (H-2D(b)K(b)) recognizing an MHC class I molecule, H-2K(d), in mice.
    Tashiro-Yamaji J; Kubota T; Yoshida R
    Gene; 2006 Dec; 384():1-8. PubMed ID: 17010536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin graft enhancement studies with antigenic differences arising from the H-2K, H-2D, and H-2L loci.
    McKenzie IF; Henning MM; Morgan GM
    Transplantation; 1980 Jun; 29(6):439-43. PubMed ID: 6996234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of immune responsiveness to tumour grafts (enhancement or inhibition) induced in mice by allogeneic embryos.
    Vlachov K; Kinsky RG; Voisin GA
    Folia Biol (Praha); 1983; 29(6):419-23. PubMed ID: 6667745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of marrow graft rejection in murine model systems.
    Dennert G; Knobloch C; Yankelevich B
    Transplant Proc; 1987 Dec; 19(6 Suppl 7):12-7. PubMed ID: 3321640
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevention of bone marrow and cardiac graft rejection in an H-2 haplotype disparate mouse combination by an anti-LFA-1 antibody.
    Cavazzana-Calvo M; Sarnacki S; Haddad E; De Coene C; Calise D; Yvon E; Cerf-Bensussan N; Fischer A
    Transplantation; 1995 Jun; 59(11):1576-82. PubMed ID: 7778173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-CD20 antibody suppresses anti-HLA antibody formation in a HLA-A2 transgenic mouse model of sensitization.
    Wu GD; He Y; Chai NN; Toyoda M; Dunn R; Kehry MR; Klein AS; Jordan SC
    Transpl Immunol; 2008 Jul; 19(3-4):178-86. PubMed ID: 18595710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The T cell populations mediating rejection of MHC class I disparate skin grafts in mice.
    Rosenberg AS
    Transpl Immunol; 1993; 1(2):93-9. PubMed ID: 7915953
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of IgG and IgM alloantibodies in the enhancement of mouse skin allografts and the relation with their opsonizing capacity in vivo.
    Lems SP; Tamboer WP; Capel PJ; Koene RA
    J Immunol; 1981 Aug; 127(2):665-9. PubMed ID: 7019328
    [No Abstract]   [Full Text] [Related]  

  • 14. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4+ T cells.
    Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
    Transplantation; 2006 Aug; 82(4):582-91. PubMed ID: 16958183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific tolerance induction of allo-K(b)-skin grafts by FK506 in the CD8-depleted H-2(k) recipients required low amounts of K(b)-antigen.
    Chen BG; Liu Z; Wu Y
    Transpl Immunol; 2005 Oct; 15(1):9-16. PubMed ID: 16223668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The production of adult chimeras by the use of monoclonal anti-host H-2K antibody.
    Wegmann TG; Carlson GA; Drell DW
    Transplant Proc; 1981 Mar; 13(1 Pt 1):654-6. PubMed ID: 7268886
    [No Abstract]   [Full Text] [Related]  

  • 17. Split tolerance to the MHC class I molecule H-2Dd in animals transgenic for its soluble analog.
    Hunziker RD; Lynch F; Shevach EM; Margulies DH
    Hum Immunol; 1997 Feb; 52(2):82-94. PubMed ID: 9077557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural relation of murine "third locus" (H-2L) major histocompatibility antigens to the products of H-2K and H-2D loci.
    Rose SM; Hansen TH; Cullen SE
    J Immunol; 1980 Nov; 125(5):2044-50. PubMed ID: 7430620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The differential destructive and enhancing effects of anti-H-2K, H-2D, and anti-Ia antisera on murine skin allografts.
    McKenzie IF; Henning MM
    J Exp Med; 1978 Feb; 147(2):611-6. PubMed ID: 342669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of antiserum and complement in the acute antibody-mediated rejection of mouse skin allografts in strain combinations with increasing histoincompatibility.
    Berden JH; Gerlag PG; Hagemann JF; Koene RA
    Transplantation; 1977 Sep; 24(3):175-82. PubMed ID: 339430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.